Preparation and Study of Folate Modified Albumin Targeting Microspheres

Figure 4

Profiles of in vitro release of free Nintedanib and ND-FSA NPS (5 mg/mL for each) in 3 dissolution media (100 mL), namely, HCl solution (pH 1.2) (a), phosphate buffered solution (PBS) with 0.5% Tween 80 (pH 7.4) (b), and double deionized water (DDW) (c), at distinct time points (within 24 h mean ± SD, n = 3).